Census
How many terpenes are there? A source-audited history of competing counts and a reproducible two-source identity union.
Read the project →Research outline
One portfolio, several levels of evidence
Our work moves from literature discovery and chemical identity through receptor hypotheses, pathway inference, computational classification, and preparation-level biological evidence. Each project keeps its source, method, and uncertainty visible.
01 / Project index
Current projects
Claims
Promotional terpene effects recast as hypotheses, linked to receptor evidence without confusing mechanism with efficacy.
Read the project →Classifier
Auditable molecular classification using canonical identity, SMILES representations, Morgan fingerprints, and rejection boundaries.
Read the project →TerpNet
General-purpose terpene pathway graph framework for genome/transcript/docking evidence, distinct from cannabis-only profile models.
Read the project →Terpotype
A name-independent seven-profile description of measured cannabis terpene chemistry.
Read the manuscript →Cannabis metabolic network
Cannabis-specific causal-network model for terpene profile variation (genotype, regulation, development, environment, and retention).
Read the project →Cannabis strain analysis
Record-level variability analysis that separates measured chemistry from names, genotype, environment, and causal claims.
Read the project →Artemisia
A frozen scoping review of terpene diversity, biosynthetic evolution, and bounded antiparasitic evidence.
Read the review package →Absinthe
A critical evidence map testing whether absinthe should be described as a classic psychedelic.
Read the project →Terpene PubMed
A nightly search matrix that makes literature density visible across terpene and topic combinations.
Read the project →Functional Flavors
Research surfaces for flavor chemistry, including cinnamaldehyde variation across cinnamon types.
Read the project →NAuTILUS
A GPU-accelerated design for large-scale terpene–protein interaction ranking, docking, and graph integration.
Read the project →ADHD attention
A 2015–2025 metasurvey emphasizing reaction-time variability, network dynamics, and evidence quality.
Read the project →KB PubMed
Automated PubMed collection, metadata extraction, classification, and knowledge-base intake for terpene research.
Read the project →02 / Manuscript roadmap
Submission-ready directions
Manuscript packages use journal-specific structures and declarations. Author metadata is recorded conservatively; unconfirmed details remain explicitly marked for verification.
| Manuscript | Recommended journal | Framing |
|---|---|---|
| Census | Journal of Natural Products Discovery | Source-audited identity census with chemometric and data-mining methods |
| Claims | Pharmacology Research & Perspectives | Evidence-based pharmacology perspective, not an efficacy catalogue |
| Terpotype | Cannabis & Cannabinoid Research | Cannabis chemistry and profile classification |
| Cannabis variability | Metabolomics | Compositional data analysis, missingness, and uncertainty |
| Absinthe | Journal of Psychedelic Studies | Critical review and evidence map of a psychedelic claim |
| Artemisia | Phytochemistry Reviews | Chemistry-led frozen scoping review with bounded integration |
| Classifier / TerpNet | JCIM / Plant Methods | Reproducible computational methods with held-out validation |
| ADHD attention | Journal of Attention Disorders | Attention research review with complete citations and study context |
03 / Publication priority
Recommended publish sequence
Order is designed to maximize throughput and quality control while minimizing dependency risk.
| Wave | Manuscripts | Reasoning |
|---|---|---|
| Wave 1 (ready now) | Census; Claims; Terpotype; Absinthe; Artemisia | Formatting and metadata are near complete; these can move quickly through final checks. |
| Wave 2 (in progress) | Classifier / TerpNet | Methods/figures are being finalized before submit-ready formatting lock. |
| Wave 3 (active development) | Cannabis metabolic network; ADHD attention | Core narratives and evidence packages are still being assembled. |
04 / Working status
Research and manuscript progress
Status reflects the latest project-agent handoff. “Complete” means the current package has been formatted and checked; remaining author fields are still subject to confirmation.
| Project | Current status | Next handoff |
|---|---|---|
| Census | Journal-format checks complete; formatting verified on current branch | Census agent is validating final tables and preparing submission-ready files |
| Claims | Formatted package complete and synced | Claims agent is running final journal-style proofing and submit-readiness review |
| Classifier | Journal-format verification in progress | Classifier agent is completing JCIM methods narrative and figure set |
| Terpotype / strain variability | Author and CRediT metadata finalized; manuscripts formatted | Strain team is validating funding/competing-interest statements for CCR and Metabolomics tracks |
| TerpNet | Repository and workflow updates pushed with supporting SQL artifacts | TerpNet agent is assembling Plant Methods methods, reproducibility, and figure evidence package |
| Cannabis metabolic network | In progress; pathway coverage and curation artifacts being normalized for review | Cannabis network agent is updating the strain-based causal model and graph-validation snapshots independent of TerpNet |
| Absinthe | Commit synced to manuscript branch and package committed | Absinthe agent is finalizing evidence map and preparing JPS submission checklist |
| Artemisia | Formatted package complete and synced | Artemisia agent is confirming references and submission metadata |
| ADHD attention | In progress on evidence matrix and reporting structure | ADHD agent is finishing manuscript narrative and target-journal style checks |
05 / Evidence rules
Claims stay smaller than the data.
A database record is not a validated natural product. A receptor association is not efficacy. A docking score is not affinity. A graph path is not proof of in-vivo production. We preserve those distinctions throughout the portfolio.